111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-32.44%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-44.51%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
486.80%
5Y OCF/share CAGR above 1.5x PUK's 12.19%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
2310.96%
3Y OCF/share CAGR similar to PUK's 2385.75%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
No Data
No Data available this quarter, please select a different quarter.
354.02%
Positive 5Y CAGR while PUK is negative. John Neff might view this as a strong mid-term relative advantage.
-35.62%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
51.34%
5Y equity/share CAGR at 50-75% of PUK's 96.18%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
46.80%
3Y equity/share CAGR above 1.5x PUK's 27.76%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
135.88%
5Y dividend/share CAGR above 1.5x PUK's 27.08%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
55.15%
Our short-term dividend growth is positive while PUK cut theirs. John Neff views it as a comparative advantage in shareholder returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
